How NovoLog® is Different

What are the benefits of NovoLog®?

NovoLog® is a fast-acting (also called rapid-acting) insulin designed to work like the insulin that the body makes after meals. It is called an insulin analog, which is a slightly altered form of the insulin made by the body. This allows NovoLog® to be absorbed more quickly by the body. Since it is absorbed quickly, NovoLog® acts fast to provide the insulin response needed by the body at mealtime.

NovoLog® and nighttime blood sugar

NovoLog® has a low rate of nighttime low blood sugar, or nocturnal hypoglycemia. In a study of people with type 1 diabetes, people taking NovoLog® had fewer nighttime low blood sugar episodes than those taking regular human insulin. Learn more about the signs and symptoms of low blood sugar on Cornerstones4Care.com.

NovoLog® can keep up with your routine

NovoLog® works differently than regular human insulin. NovoLog® is fast-acting, so it can be taken just before your meal, whenever you prefer to eat. This may help you live your life on your schedule when it comes to exercising, activities with friends, and times when you are on the go. Be sure to consult with your doctor to adjust your insulin level for these types of changes in your daily schedule.

NovoLog® is stable in storage

NovoLog® FlexPen®, 3-mL PenFill® cartridge,* and 10-mL vial do not need to be refrigerated once they've been opened, so they can be stored on a nightstand, in a purse, and many other places.

NovoLog^® FlexPen^®, 3-mL PenFill^® cartridge, * and 10-mL vial:stable in storage

	Temperature	Storage
In-user†‡ (opened)	Room temperature (up to 86°F)	28days
Not in-use (unopened)	Room temperature (up to 86°F)	28days
Not in-use (unopened)	Refrigerated	until expiration date

NovoLog^®: designed to take the heat

• NovoLog^® in the 3-mL PenFill^® cartridge and vial is stable at temperatures up to 86°F once in use(opened) and does not require refrigeration
• NovoLog^® remains heat stable in pumps at normal body temperature up to 98.6°F

NovoLogNovoLog^®: more time between insulin changes in pumps

• NovoLog^® is the first and only rapid-acting insulin with an extended in-use time of up to 6 days in external insulin pump reservoirs

NovoLog® is safe and effective for use in a pump

NovoLog® has been approved for use in pumps since 2001. NovoLog® has been proven safe and effective for use in insulin pumps in children age 2 and older with type 1 diabetes and adults with diabetes.

NovoLog® is the first fast-acting insulin that can be used for up to 6 days in a pump reservoir before it needs to be changed. When used in a pump, NovoLog® had a lower rate of clogs compared with other insulin analogs. Learn more about using NovoLog® in a pump.

When considering NovoLog® or NovoLog® in a pump, it is important to have a good understanding of how NovoLog® works.

Next: How NovoLog® Works >